Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP): results of the Phase 2 AIO trial PACET-CUP

被引：0
|
作者：
Gunnar Folprecht
Karolin Trautmann
Alexander Stein
Gerdt Huebner
Michael Stahl
Stefan Kasper
Albrecht Kretzschmar
Claus-Henning Köhne
Viktor Grünwald
Ralf-Dieter Hofheinz
Katharina Schütte
Harald Löffler
Carsten Bokemeyer
Alwin Krämer
机构：
[1] Technische Universität Dresden/University Hospital Carl Gustav Carus,West German Cancer Centre
[2] Medical Department I,Department of Hematology, Hemostaseology, Oncology & Stem Cell Transplantation
[3] University Medical Center Hamburg-Eppendorf,West
[4] oho! ostholstein-onkologie,German Cancer Centre Essen
[5] Evangl. Kliniken Essen-Mitte,Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V
[6] Department of Medical Oncology,undefined
[7] University Hospital Essen,undefined
[8] Department of Medical Oncology,undefined
[9] MVZ Mitte,undefined
[10] University Clinic for Internal Medicine,undefined
[11] Oncology und Hematology,undefined
[12] Hannover Medical School,undefined
[13] University Hospital Essen,undefined
[14] University Medical Center Mannheim,undefined
[15] Tagestherapiezentrum am ITM,undefined
[16] Marienhospital,undefined
[17] University of Heidelberg,undefined
来源：
British Journal of Cancer | 2021年 / 124卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：721 / 727
页数：6
相关论文
共 50 条
  • [1] Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP): results of the Phase 2 AIO trial PACET-CUP
    Folprecht, Gunnar
    Trautmann, Karolin
    Stein, Alexander
    Huebner, Gerdt
    Stahl, Michael
    Kasper, Stefan
    Kretzschmar, Albrecht
    Koehne, Claus-Henning
    Gruenwald, Viktor
    Hofheinz, Ralf-Dieter
    Schuette, Katharina
    Loeffler, Harald
    Bokemeyer, Carsten
    Kraemer, Alwin
    [J]. BRITISH JOURNAL OF CANCER, 2021, 124 (04) : 721 - 727
  • [2] Paclitaxel/carboplatin with or without cetuximab for treatment of carcinoma with unknown primary (PACET-CUP): Results of a multi-center randomized phase II AIO trial.
    Kraemer, Alwin
    Stein, Alexander
    Huebner, Gerdt
    Stahl, Michael
    Kasper, Stefan
    Kretzschmar, Albrecht
    Kohne, Claus-Henning
    Gruenwald, Viktor
    Hofheinz, Ralf
    Schuette, Katharina
    Loeffler, Harald
    Bokemeyer, Carsten
    Folprecht, Gunnar
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Paclitaxel/carboplatin (PC) plus bevacizumab/erlotinib as first-line treatment for patients (pts) with carcinoma of unknown primary (CUP) site
    Greco, F. A.
    Burris, H. A., III
    Spigel, D. R.
    Thompson, D. S.
    Waterhouse, D. M.
    Hanson, S.
    Vazquez, E. R.
    Hainsworth, J. D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Paclitaxel/Carboplatin With or Without Belinostat as Empiric First-Line Treatment for Patients With Carcinoma of Unknown Primary Site: A Randomized, Phase 2 Trial
    Hainsworth, John D.
    Daugaard, Gedske
    Lesimple, Thierry
    Huebner, Gerdt
    Greco, F. Anthony
    Stahl, Michael J.
    Bueschenfelde, Christian Meyer Zum
    Allouache, Djelila
    Penel, Nicolas
    Knoblauch, Poul
    Fizazi, Karim S.
    [J]. CANCER, 2015, 121 (10) : 1654 - 1661
  • [5] A phase II trial of carboplatin, gemcitabine and capecitabine in patients with carcinoma of unknown primary site (CUP).
    Schneider, BJ
    Muler, J
    Philip, P
    Kalemkerian, G
    El-Rayes, B
    Griffith, K
    Zalupski, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 330S - 330S
  • [6] Paclitaxel/Carboplatin plus Bevacizumab/Erlotinib in the First-Line Treatment of Patients with Carcinoma of Unknown Primary Site
    Hainsworth, John D.
    Spigel, David R.
    Thompson, Dana S.
    Murphy, Patrick B.
    Lane, Cassie M.
    Waterhouse, David M.
    Naot, Yuval
    Greco, F. Anthony
    [J]. ONCOLOGIST, 2009, 14 (12): : 1189 - 1197
  • [7] Gemcitabine (G) and irinotecan (CPT-11) as first-line therapy for carcinoma (ca) of unknown primary (CUP): An NCCTG phase II trial
    Holtan, S. G.
    Foster, N. R.
    Erlichman, C. E.
    Aubry, M.
    Ames, M. M.
    Safgren, S.
    Steen, P. D.
    Morton, R. F.
    Graham, D.
    Goetz, M. P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Combination Treatment With Paclitaxel, Carboplatin, and Cetuximab (PCE) as First-Line Treatment in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma
    Ueda, Yuri
    Enokida, Tomohiro
    Okano, Susumu
    Fujisawa, Takao
    Ito, Kazue
    Tahara, Makoto
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [9] Simplified/Same Day(s)-GOLF as First-line Treatment of Metastatic Carcinoma of Unknown Primary (CUP), Suggestive of Pancreatobiliary Tumors
    Saif, Muhammad Wasif
    Wasif, Komal
    Goodman, Martin D.
    Hegde, Sanjay
    Sterling, Mark
    Yacavone, Robert
    Jaiswal, Sunny
    Weinstein, Barbara
    Daly, Kevin
    Relias, Valerie
    [J]. JOURNAL OF THE PANCREAS, 2019, 20 (05): : 151 - 154
  • [10] Gemcitabine and Irinotecan as First-Line Therapy for Carcinoma of Unknown Primary: Results of a Multicenter Phase II Trial
    Holtan, Shernan G.
    Steen, Preston D.
    Foster, Nathan R.
    Erlichman, Charles
    Medeiros, Fabiola
    Ames, Matthew M.
    Safgren, Stephanie L.
    Graham, David L.
    Behrens, Robert J.
    Goetz, Matthew P.
    [J]. PLOS ONE, 2012, 7 (07):
12345